Diasorin SpA (STU:34D) Long-Term Capital Lease Obligation : €0 Mil (As of Mar. 2025)

View and export this data going back to 2007. Start your Free Trial

What is Diasorin SpA Long-Term Capital Lease Obligation?

Diasorin SpA's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was €0 Mil.

Diasorin SpA's quarterly Long-Term Capital Lease Obligation increased from Sep. 2024 (€0 Mil) to Dec. 2024 (€67 Mil) but then declined from Dec. 2024 (€67 Mil) to Mar. 2025 (€0 Mil).

Diasorin SpA's annual Long-Term Capital Lease Obligation stayed the same from Dec. 2022 (€0 Mil) to Dec. 2023 (€0 Mil) but then increased from Dec. 2023 (€0 Mil) to Dec. 2024 (€67 Mil).

Diasorin SpA Long-Term Capital Lease Obligation Historical Data

The historical data trend for Diasorin SpA's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diasorin SpA Long-Term Capital Lease Obligation Chart

Diasorin SpA Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

67.36

Diasorin SpA Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															-	66.13	-	67.36	-

Diasorin SpA (STU:34D) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Diasorin SpA Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Diasorin SpA's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Diasorin SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diasorin SpA (STU:34D) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

DSRLF:USA DIA:Italy DIAm:UK 0GZX:UK 34D:Germany DIAS:Austria

Address

Via Crescentino Snc, Saluggia, Vercelli, ITA, 13040

Website

https://www.diasoringroup.com

DiaSorin, headquartered in Italy, is a global provider of in vitro diagnostics, or IVD, which refers to testing done on samples taken from the human body, such as blood and tissue. DiaSorin produces and markets testing reagent kits for immunodiagnostics (about 65% of total sales) and molecular diagnostics (about 20%) and has a total installed base of about 9,000 diagnostic systems. Instruments and other revenue contribute about 15% of total sales. DiaSorin's largest market in 2023 was North America, which accounted for 48% of non-covid revenue, followed by Europe (35%) and the Rest of the World (18%).

Diasorin SpA Headlines

No Headlines